Journal Highlights From the November and December Issues of JAMDA

Despite research showing the benefits of nonpharmacologic treatment for behavioral expressions of dementia, clinicians often opt for using psychotropic medications such as antipsychotics, even though these agents are associated with adverse events and new behavioral expressions. For that reason, the Alzheimer’s Association devoted its in-person inaugural April 2019 meeting of the Dementia Care Provider Roundtable, an ongoing consortium of thought leaders in long-term and community-based care, to the challenges underlying the wider implementation of behavioral support and person-centered approaches.